Catalyst Wire Dossier Catalyst Wire Dossier
EMA safety_alert · 2012-02-16

European Medicines Agency confirms positive benefit-risk balance of orlistat-containing medicines

View source ↗

Summary

EMA confirms that orlistat-containing medicines have a positive benefit–risk balance and are kept available, with ongoing monitoring of safety and effectiveness…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Orlistat (orlistat)